Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia and cause of significant morbidity and mortality. Its increasing prevalence in aging societies constitutes a growing challenge to ...

A 24-week treatment with bofanglutide for patients with type 2 diabetes showed meaningful glycemic control, weight loss, and improvements in cardiometabolic risk factors — reductions which seemed at ...

At a nurse practitioner-owned and operated clinic, researchers performed continuous PDSA cycles of quality improvement to ...

Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the major risk factors for CVD, obesity and diabetes mellitus have received considerable attention in terms of public ...

As we know diabetes mellitus is the most common metabolic endocrine disorder. According to the WHO and American Diabetes Mellitus, diabetes mellitus is the 3rd leading cause of death if we were to ...

Introduction Effective management of type 2 diabetes mellitus (T2DM) consists of lifestyle modification and therapy optimisation. While glycaemic monitoring can be used as a tool to guide these ...

Objectives Long-term effects of gastric bypass (GBP) surgery have been presented in observational and randomised studies, but there are only limited data for persons with obesity and type 2 diabetes ...

Medical guidelines are long, dense, and hard to use mid-clinic. MD2SKILL extracts the actionable, decision-making parts and converts them into structured prompts (skills) that work with any AI tool.

Artificial intelligence (AI) offers enhanced predictive capabilities that can substantially enhance the prevention of postpartum diabetes. Objective: This systematic review and meta-analysis aimed to ...

1 Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a cornerstone therapy for the management of type 2 diabetes mellitus (T2DM) and obesity, offering clinically ...